A new analysis of 6,367 people with MASLD from the National Health and Nutrition Examination Survey (1999-2018) ties moderate dietary omega-3 intake to lower all-cause mortality. Published in Nutrition Research, the study found the relationship is not linear: survival benefit rises with intake up to a point, then plateaus. That point is roughly 2.14 grams per day.
The researchers used 24-hour dietary recalls to estimate omega-3 intake, then ran multivariable Cox regression and restricted cubic spline analysis. The result was an L-shaped curve with a clear inflection at 2.14 g/day of n-3 polyunsaturated fatty acids. The primary omega-3 in the diet of these patients was alpha-linolenic acid, the plant form.
Why would omega-3 help the liver? The fatty acids dampen de novo lipogenesis, reduce inflammation, and improve insulin sensitivity, all of which matter in MASLD. The study does not claim causation, but the dose-response shape supports the idea that a moderate, consistent intake is the useful target, not a maximum-dose approach.
What does 2.14 grams look like on a plate? A 100-gram serving of cooked Atlantic salmon carries roughly 1.5 to 2 grams of EPA and DHA. Mackerel is similar. Sardines, herring, and anchovies also land in that range. Walnuts, ground flaxseed, and chia provide ALA, which the body converts only partially, so fish remains the most efficient route.
The moderation angle matters for the red-yellow-green system on this site. Fatty fish rates as a fatty liver friendly food: it is a protein with unsaturated fat, no added sugar, and no processing red flags. The limit side of the ledger is the same omega-3 story in supplement form, where dosing can overshoot quickly and interactions need a clinician.
Two or three servings of fatty fish a week, a small handful of walnuts, and a spoon of ground flaxseed put a reader in the moderate range most days of the week. That is the practical translation of the 2.14-gram number.
The study design deserves a close read because it explains both the strength and the limits of the finding. The researchers drew 6,367 adults with MASLD from the National Health and Nutrition Examination Survey across two decades, from 1999 through 2018. Diet was measured with 24-hour recalls, which are imperfect tools because people forget and underreport, but the sample size and the national sampling frame give the pattern real weight. The outcome was all-cause mortality, tracked through linked death records. Cox regression and restricted cubic splines both pointed the same way: moderate intake was tied to lower mortality, and the benefit flattened out near 2.14 grams per day. An L-shaped relationship like this is common in nutrition epidemiology, where deficiency and excess both look worse than the middle.
The mechanism story helps explain why the curve bends the way it does. Omega-3 fatty acids, especially EPA and DHA, suppress hepatic lipogenesis, lower triglycerides, and improve insulin sensitivity. They also quiet inflammation, which matters in MASLD because inflammation is the step between simple fat and progressive liver injury. The alpha-linolenic acid from plants does some of this work, but the conversion to EPA and DHA in the human body is limited, which is why the authors note that fish sources dominate the efficient end of the intake range. A reader who prefers plants can still get meaningful ALA from walnuts, flaxseed, and chia, but the dose has to be larger to approach the same effect.
Putting 2.14 grams on a real plate is easier than it sounds. A 100-gram cooked portion of Atlantic salmon provides roughly 1.5 to 2 grams of combined EPA and DHA, so one salmon dinner nearly covers the daily target. Mackerel, sardines, herring, and anchovies land in a similar range. Two or three fatty fish meals a week plus a small handful of walnuts and a spoon of ground flaxseed keeps most days in the moderate zone without any supplement at all. Canned sardines and canned salmon count too, and they are cheaper and shelf-stable, which removes the freshness excuse.
The supplement question is where caution belongs. Fish oil capsules can push intake far past 2.14 grams quickly, and high-dose omega-3 can thin the blood and interact with anticoagulants. The study measured food, not pills, so it cannot bless any capsule dose. A reader taking blood thinners, or considering omega-3 supplements for any reason, should bring the question to a clinician. On the food side there is no such caution: fatty fish, walnuts, and flaxseed are simply part of a Mediterranean-style pattern, and they rate favorably on this site’s food logic.
There is a Mediterranean pattern hiding inside the omega-3 data, which is the right way for this site to close the loop. Fatty fish, walnuts, olive oil, and vegetables are the foods that cluster around the omega-3 sweet spot, and they are also the foods at the center of the Mediterranean-style eating pattern that AASLD guidance points to for MASLD. The omega-3 study adds a mortality outcome to that pattern, which is stronger evidence than a liver-fat scan alone. A reader who builds meals around salmon or sardines, a handful of walnuts, olive oil for cooking, and a plate of vegetables is simultaneously hitting the omega-3 target, the fiber target, and the saturated-fat limit. That is the efficiency of a pattern over a supplement, and it is why the food-first framing of the study matters.
The reader-facing version of this study, held to the one standard this site applies to every food, is that the serving matters and the pattern beats the pill. Two fatty fish meals a week, a handful of walnuts, and a spoon of ground flaxseed put most days in the moderate range without counting grams. That is the whole omega-3 message in one line.
How much omega-3 came out as the sweet spot?
The analysis found an L-shaped relationship between dietary omega-3 intake and all-cause mortality in people with MASLD, with an inflection point at about 2.14 grams per day. Intake above that level did not add further survival benefit in the model.
Which omega-3 foods count toward that number?
Fatty fish like salmon, mackerel, sardines, and herring deliver EPA and DHA directly. Walnuts, flaxseed, and chia seeds provide alpha-linolenic acid, which the body converts only partially, so fish remains the most efficient source.
Does this mean supplements are necessary?
No. The study measured dietary intake, not supplements. Two to three servings of fatty fish a week plus plant sources can reach the moderate range, and anyone considering a supplement should talk to a clinician first.